The global perfusion imaging market accounted for USD 2.34 billion in 2023 and is expected to reach USD 3.40 billion by 2034 with a CAGR of 3.46% during the forecast period 2024-2034. The market will grow as a result of government initiatives, a growing geriatric population, increasing organ transplantation rates, rising prevalence of chronic diseases, and technological advancements.
Personalized medicine - wherein therapies are customized to each patient's unique traits, including physiological and biological ones - is becoming more and more popular. Personalized diagnosis, treatment planning, and therapy monitoring are made possible by perfusion imaging, which offers useful physiological data regarding tissue perfusion and blood flow dynamics. Perfusion imaging will become more and more necessary as personalized medicine becomes more popular. For instance, Ion Beam Applications S.A. introduced AKURACY, a unique combination solution for PET myocardial perfusion-based imaging, in May 2023. At the European Association of Cardiovascular Imaging (EACVI) meeting in Spain, this cutting-edge technique was introduced.
By modality type, the SPECT & PET segment accounted for the highest revenue-grossing segment in the global perfusion imaging market in 2023 owing to the high sensitivity and specificity of SPECT & PET imaging techniques, enabling precise assessment of tissue perfusion and aiding in accurate diagnosis and treatment planning for various medical conditions. For instance, Penumbra expanded its range of devices for clot removal in stroke treatment in February 2022 with the release of its Indigo® Aspiration System Lightning 12. Additionally, the magnetic resonance imaging (MRI) segment is predicted to grow at the fastest CAGR during the forecast period owing to the advancements in MRI technology, including improved spatial and temporal resolution, multiparametric imaging capabilities, and the development of advanced contrast agents, enhancing its utility for perfusion imaging across diverse clinical applications.
By application, the coronary artery disease (CAD) segment accounted for the highest revenue-grossing segment in the global perfusion imaging market in 2023 owing to the high prevalence of coronary artery disease globally, increasing demand for accurate diagnostic tools for early detection, monitoring, and treatment evaluation, and the effectiveness of perfusion imaging techniques in assessing myocardial perfusion and identifying ischemic regions associated with CAD. For instance, Siemens Healthineers stated in January 2022 that it would extend its oncology offering by acquiring Varian Medical Systems, a pioneer in cancer care solutions. Additionally, the myocardial infarction (MI) segment is predicted to grow at the fastest CAGR during the forecast period owing to the growing incidence of myocardial infarction globally, rising awareness regarding the importance of early diagnosis and prompt treatment, and the increasing adoption of perfusion imaging techniques for accurate assessment of myocardial perfusion deficits and infarcted regions, driving market growth in this segment.
By end-user, the hospital's segment accounted for the highest revenue-grossing segment in the global perfusion imaging market in 2023 owing to the increasing patient admissions for diagnostic imaging procedures, availability of advanced imaging equipment in hospital settings, and the rising preference of healthcare providers for comprehensive diagnostic facilities, driving higher demand for perfusion imaging services in hospitals. For instance, Fujifilm announced in January 2022 the release of the FDR Visionary Suite, a comprehensive digital radiography system with enhanced diagnostic capabilities thanks to upgraded imaging technologies. Additionally, the ambulatory surgery centers segment is estimated to grow at the fastest CAGR during the forecast period owing to the rising trend towards minimally invasive procedures, the increasing prevalence of chronic diseases necessitating outpatient diagnostic evaluations, and the expanding capabilities of ambulatory surgery centers to provide advanced imaging services, driving the growth of perfusion imaging utilization in this segment.
North American region is estimated to have the highest revenue share in 2023 owing to the advanced healthcare infrastructure, high adoption of advanced imaging technologies, strong research and development activities, presence of major market players, and increasing prevalence of chronic diseases driving the demand for perfusion imaging solutions in North America. However, The Asia Pacific region is anticipated to grow at the fastest compound annual growth rate (CAGR) during the forecast period due to the region's rapidly developing healthcare infrastructure, rising healthcare costs, rising chronic disease prevalence, rising awareness of early disease detection, and emerging economies adoption of advanced imaging technologies, which are all driving the demand for perfusion imaging solutions in the region. For instance, Medtronic announced in January 2022 that the FDA had approved their MicraTM AV Transcatheter Pacing System, which is the smallest pacemaker in the world with atrioventricular (AV) synchrony and offers advanced cardiac pacing choices.
This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.
Personalized medicine - wherein therapies are customized to each patient's unique traits, including physiological and biological ones - is becoming more and more popular. Personalized diagnosis, treatment planning, and therapy monitoring are made possible by perfusion imaging, which offers useful physiological data regarding tissue perfusion and blood flow dynamics. Perfusion imaging will become more and more necessary as personalized medicine becomes more popular. For instance, Ion Beam Applications S.A. introduced AKURACY, a unique combination solution for PET myocardial perfusion-based imaging, in May 2023. At the European Association of Cardiovascular Imaging (EACVI) meeting in Spain, this cutting-edge technique was introduced.
By modality type, the SPECT & PET segment accounted for the highest revenue-grossing segment in the global perfusion imaging market in 2023 owing to the high sensitivity and specificity of SPECT & PET imaging techniques, enabling precise assessment of tissue perfusion and aiding in accurate diagnosis and treatment planning for various medical conditions. For instance, Penumbra expanded its range of devices for clot removal in stroke treatment in February 2022 with the release of its Indigo® Aspiration System Lightning 12. Additionally, the magnetic resonance imaging (MRI) segment is predicted to grow at the fastest CAGR during the forecast period owing to the advancements in MRI technology, including improved spatial and temporal resolution, multiparametric imaging capabilities, and the development of advanced contrast agents, enhancing its utility for perfusion imaging across diverse clinical applications.
By application, the coronary artery disease (CAD) segment accounted for the highest revenue-grossing segment in the global perfusion imaging market in 2023 owing to the high prevalence of coronary artery disease globally, increasing demand for accurate diagnostic tools for early detection, monitoring, and treatment evaluation, and the effectiveness of perfusion imaging techniques in assessing myocardial perfusion and identifying ischemic regions associated with CAD. For instance, Siemens Healthineers stated in January 2022 that it would extend its oncology offering by acquiring Varian Medical Systems, a pioneer in cancer care solutions. Additionally, the myocardial infarction (MI) segment is predicted to grow at the fastest CAGR during the forecast period owing to the growing incidence of myocardial infarction globally, rising awareness regarding the importance of early diagnosis and prompt treatment, and the increasing adoption of perfusion imaging techniques for accurate assessment of myocardial perfusion deficits and infarcted regions, driving market growth in this segment.
By end-user, the hospital's segment accounted for the highest revenue-grossing segment in the global perfusion imaging market in 2023 owing to the increasing patient admissions for diagnostic imaging procedures, availability of advanced imaging equipment in hospital settings, and the rising preference of healthcare providers for comprehensive diagnostic facilities, driving higher demand for perfusion imaging services in hospitals. For instance, Fujifilm announced in January 2022 the release of the FDR Visionary Suite, a comprehensive digital radiography system with enhanced diagnostic capabilities thanks to upgraded imaging technologies. Additionally, the ambulatory surgery centers segment is estimated to grow at the fastest CAGR during the forecast period owing to the rising trend towards minimally invasive procedures, the increasing prevalence of chronic diseases necessitating outpatient diagnostic evaluations, and the expanding capabilities of ambulatory surgery centers to provide advanced imaging services, driving the growth of perfusion imaging utilization in this segment.
North American region is estimated to have the highest revenue share in 2023 owing to the advanced healthcare infrastructure, high adoption of advanced imaging technologies, strong research and development activities, presence of major market players, and increasing prevalence of chronic diseases driving the demand for perfusion imaging solutions in North America. However, The Asia Pacific region is anticipated to grow at the fastest compound annual growth rate (CAGR) during the forecast period due to the region's rapidly developing healthcare infrastructure, rising healthcare costs, rising chronic disease prevalence, rising awareness of early disease detection, and emerging economies adoption of advanced imaging technologies, which are all driving the demand for perfusion imaging solutions in the region. For instance, Medtronic announced in January 2022 that the FDA had approved their MicraTM AV Transcatheter Pacing System, which is the smallest pacemaker in the world with atrioventricular (AV) synchrony and offers advanced cardiac pacing choices.
This extensive research report concentrates on the size and projections of the global and regional markets from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Modality Type, Application, and End-User
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of the Top 10+ Major Market Players
Segmentation: Perfusion Imaging Market Report 2023 - 2034
Perfusion Imaging Market Analysis & Forecast by Modality Type 2023 - 2034 (Revenue USD Bn)
- Single Photon Emission Computed Tomography (SPECT)
- Positron Emission Tomography (PET)
- Magnetic Resonance Imaging (MRI)
- Computed tomography (CT)
- Doppler echocardiography
Perfusion Imaging Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Coronary artery disease (CAD)
- Myocardial infarction (MI)
- Cardiomyopathy
- Epilepsy
- Dementia
- Transplant evaluation
- Brain Trauma
- Pulmonary embolism (PE)
- Osteonecrosis
- Others
Perfusion Imaging Market Analysis & Forecast by End-User 2023 - 2034 (Revenue USD Bn)
- Hospitals
- Ambulatory Surgery Canter
- Diagnostic Imaging Centers
- Others
Perfusion Imaging Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Perfusion Imaging Market: Modality Type Estimates & Trend Analysis
8. Perfusion Imaging Market: Application Estimates & Trend Analysis
9. Perfusion Imaging Market: End-User Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Perfusion Imaging Market
12. Europe Global Perfusion Imaging Market
13. Asia Pacific Global Perfusion Imaging Market
14. Latin America Global Perfusion Imaging Market
15. MEA Global Perfusion Imaging Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- GE Healthcare
- Siemens Healthineers
- Philips Healthcare
- Canon Medical Systems Corporation
- Hitachi Medical Systems
- Bracco Imaging S.p.A.
- Bayer AG
- Perimed AB
- Penumbra Inc.
- Shimadzu Corporation
- FUJIFILM Holdings Corporation
- Toshiba Medical Systems Corporation
- Neusoft Corporation
- Carestream
- Health Inc.
- Medtronic plc.
